Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$566M |
| 2 |
Meta Platforms (Facebook)
META
|
+$401M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$366M |
| 4 |
Align Technology
ALGN
|
+$356M |
| 5 |
PayPal
PYPL
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$564M |
| 2 |
Alibaba
BABA
|
+$511M |
| 3 |
Altria Group
MO
|
+$439M |
| 4 |
Revvity
RVTY
|
+$321M |
| 5 |
Merck
MRK
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.77% |
| 2 | Healthcare | 19.73% |
| 3 | Consumer Discretionary | 11.5% |
| 4 | Financials | 9.61% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
BorgWarner
BWA
$12.8B
| $2.42M | ﹤0.01% |
70,900
+15,779
| +29% | +$542K |
|
1027
Medpace
MEDP
$16.3B
| $2.4M | ﹤0.01% |
21,488
-5,244
| -20% | -$606K |
|
1028
Wynn Resorts
WYNN
$10.3B
| $2.4M | ﹤0.01% |
33,438
-113,978
| -77% | -$9.04M |
|
|
MIC
1029
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $2.4M | ﹤0.01% |
89,192
-936
| -1% | -$27.1K |
|
1030
Sabre
SABR
$716M
| $2.4M | ﹤0.01% |
367,888
+4,774
| +1% | +$35.4K |
|
1031
TD Synnex
SNX
$19.9B
| $2.39M | ﹤0.01% |
34,144
+596
| +2% | +$37.5K |
|
1032
Occidental Petroleum
OXY
$55.7B
| $2.38M | ﹤0.01% |
237,603
-139,161
| -37% | -$1.96M |
|
1033
ManpowerGroup
MAN
$2.6B
| $2.37M | ﹤0.01% |
32,298
+25,240
| +358% | +$1.81M |
|
1034
Huntington Bancshares
HBAN
$34B
| $2.32M | ﹤0.01% |
252,653
-64,065
| -20% | -$597K |
|
1035
Tango Therapeutics
TNGX
$4.21B
| $2.31M | ﹤0.01% |
+218,282
| New | +$2.23M |
|
1036
Howmet Aerospace
HWM
$109B
| $2.3M | ﹤0.01% |
137,337
-831,867
| -86% | -$13.9M |
|
1037
Perrigo
PRGO
$1.44B
| $2.29M | ﹤0.01% |
49,920
-108,470
| -68% | -$5.68M |
|
1038
Ares Management
ARES
$28.1B
| $2.28M | ﹤0.01% |
+56,437
| New | +$2.25M |
|
1039
Zai Lab
ZLAB
$2.07B
| $2.21M | ﹤0.01% |
26,544
+9,877
| +59% | +$793K |
|
1040
XPO
XPO
$23.4B
| $2.17M | ﹤0.01% |
74,242
-152,539
| -67% | -$4.39M |
|
|
FLIR
1041
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $2.15M | ﹤0.01% |
60,026
-205,605
| -77% | -$7.84M |
|
1042
AppFolio
APPF
$6.62B
| $2.15M | ﹤0.01% |
15,157
-477
| -3% | -$73.5K |
|
1043
Old Republic International
ORI
$10.9B
| $2.15M | ﹤0.01% |
145,600
-318,714
| -69% | -$5.09M |
|
|
FSDC
1044
DELISTED
FS Development Corp. Class A Common Stock
FSDC
| $2.13M | ﹤0.01% |
+191,414
| New | +$2.05M |
|
|
CYBR
1045
DELISTED
CyberArk
CYBR
| $2.13M | ﹤0.01% |
20,612
+6,545
| +47% | +$705K |
|
|
KALV
1046
DELISTED
KalVista Pharmaceuticals
KALV
| $2.13M | ﹤0.01% |
169,009
+8,233
| +5% | +$103K |
|
1047
Southwest Airlines
LUV
$21.7B
| $2.13M | ﹤0.01% |
56,680
-1,494
| -3% | -$53.1K |
|
1048
Huntington Ingalls Industries
HII
$11B
| $2.09M | ﹤0.01% |
14,859
-18,675
| -56% | -$3M |
|
|
PANA.U
1049
DELISTED
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
| $2.09M | ﹤0.01% |
+176,103
| New | +$2.03M |
|
1050
Corcept Therapeutics
CORT
$9.98B
| $2.08M | ﹤0.01% |
119,737
+21,642
| +22% | +$345K |
|
Similar funds
Janus Henderson Group's Q3 2020 Portfolio in Review
As of Q3 2020, Janus Henderson Group held 1,403 positions worth $192B, up 7.7% from $178B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q3 2020 filing shows 105 new, 521 increased, 678 reduced and 86 closed positions. Its largest new stake was Acceleron Pharma: 1,783,939 shares worth $201M. The largest sale was Apple, an estimated $564M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q3 2020 buy was Acceleron Pharma: 1,783,939 shares worth $201M.
- Janus Henderson Group added most to Booking.com in Q3 2020, an estimated $566M increase.
- Janus Henderson Group's biggest Q3 2020 reduction was Apple, cutting an estimated $564M.
- Janus Henderson Group fully exited Momenta Pharmaceuticals, Inc. in Q3 2020, selling an estimated $49.5M.
- Janus Henderson Group's ten largest holdings make up 24% of its $192B portfolio in Q3 2020.
- Janus Henderson Group opened 105 new positions and closed 86 in Q3 2020.
- Janus Henderson Group's portfolio value rose 7.7% quarter-over-quarter to $192B.
Based on Janus Henderson Group's 13F filing for Q3 2020, filed 16 Nov 2020.